News Sentiment

DBVT sentiment intelligence

DBV Technologies news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 53 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 16.49 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings

75/100 classification confidence.

Company focus 44

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+4.2% over one week, -5.3% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

DBV Technologies Q2 Earnings Call Highlights

Market Reaction

Price moving ahead of tone

59/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings 75/100 classification
One-week reaction 4.2% Price confirming higher
Trend fit Trend inactive -5.3% over four weeks
Fair value 58.1% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 35
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 44
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 8
Market source 8
Idéal Investisseur 5
Stock Titan 5
GlobeNewswire 4
MarketBeat 3
scanx.trade 2
markets.businessinsider.com 2

Event Lens

What the news is about

Classified themes
Earnings 25
Market update 19
Analyst action 3
Deals and strategy 3
Guidance 2
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-53 of 53
Idéal Investisseur Direct company coverage

DBV Technologies Stock Rebounds Nearly 4% and crosses its MM20

DBV Technologies stock has rebounded by nearly 4% and crossed its 20-day moving average (MM20), despite the SBF 120 index experiencing a slight decline. The biotech company's stock is trading at €2.99, one of the highest gains in the SBF 120, although medium-term benchmarks like

Tone
Positive 66/100
Event
Market update
Published
29 Jun 2026 09:09
Source
Idéal Investisseur
TradingView Direct company coverage

A40WEX Forecast — Price Target — Prediction for 2027

This page provides a price target and forecast information for DBV Technologies SA Sponsored ADR (A40WEX), based on analysis from 8 analysts. It includes sections for actuals and estimates for EPS, revenue, and a disclaimer that this information is not investment advice.

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 11:11
Source
TradingView
TradingView Direct company coverage

DBV Technologies SA Actuals & Estimates (EURONEXT:DBV)

This article provides comprehensive financial data and analyst estimates for DBV Technologies SA (EURONEXT:DBV). It covers the company's current stock price, historical performance, future price forecasts, earnings, revenue, market capitalization, and volatility. Key financial me

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 20:40
Source
TradingView